JA-William Brumskine - The Aurum Institute

Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial

Scriba, T.J., Fiore-Gartland, A., Penn-Nicholson, A., Mulenga, H., Mbandi, S.K., Borate, B., Mendelsohn, S.C., Hadley, K., Hikuam, C., Kaskar, M. and Musvosvi, M., 2021. Biomarker-guided tuberculosis ...
Vaccine efficacy of ALVAC-HIV and bivalent subtype c gp120–MF59 in adults.

Gray, G.E., Bekker, L.G., Laher, F., Malahleha, M., Allen, M., Moodie, Z., Grunenberg, N., Huang, Y., Grove, D., Prigmore, B. and Kee, J.J., 2021. Vaccine efficacy of ALVAC-HIV and bivalent subtype c...
Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study.

Mendelsohn, S.C., Fiore-Gartland, A., Penn-Nicholson, A., Mulenga, H., Mbandi, S.K., Borate, B., Hadley, K., Hikuam, C., Musvosvi, M., Bilek, N. and Erasmus, M., 2021. Validation of a host blood trans...
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB.

Tweed, C.D., Wills, G.H., Crook, A.M., Amukoye, E., Balanag, V., Ban, A.Y.L., Bateson, A.L.C., Betteridge, M.C., Brumskine, W., Caoili, J. and Chaisson, R.E., 2021. A partially randomised trial of pre...
Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk.

Moodie, Z., Dintwe, O., Sawant, S., Grove, D., Huang, Y., Janes, H., Heptinstall, J., Laher Omar, F., Cohen, K., De Rosa, S.C. and Zhang, L., 2022. Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine tr...
Annual Tuberculosis Preventive Therapy for Persons With HIV Infection

Churchyard, G., Cárdenas, V., Chihota, V., Mngadi, K., Sebe, M., Brumskine, W., Martinson, N., Yimer, G., Wang, S.H., Garcia-Basteiro, A.L. and Nguenha, D., 2021. Annual tuberculosis preventive thera...
Data quality in an HIV vaccine efficacy clinical trial in South Africa: Through natural disasters and with discipline.

Laher, F., Malahleha, M., Ramirez, S., Brumskine, W., Otwombe, K., Moodie, Z. and Allen, M., 2023. Data quality in an HIV vaccine efficacy clinical trial in South Africa: through natural disasters and...
Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial.

Gray, G.E., Mngadi, K., Lavreys, L., Nijs, S., Gilbert, P.B., Hural, J., Hyrien, O., Juraska, M., Luedtke, A., Mann, P. and McElrath, M.J., 2024. Mosaic HIV-1 vaccine regimen in southern African women...
Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

Garrett, N., Tapley, A., Hudson, A., Dadabhai, S., Zhang, B., Mgodi, N.M., Andriesen, J., Takalani, A., Fisher, L.H., Kee, J.J. and Magaret, C.A., 2025. Hybrid versus vaccine immunity of mRNA-1273 amo...

Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial

Vaccine efficacy of ALVAC-HIV and bivalent subtype c gp120–MF59 in adults.

Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study.

A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB.

Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk.

Annual Tuberculosis Preventive Therapy for Persons With HIV Infection

Data quality in an HIV vaccine efficacy clinical trial in South Africa: Through natural disasters and with discipline.

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial.

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

Popular Tags

Most Read

Recent Posts